Carbomer, Inc.

CARBOMER, INC., 2 OLDE CONNECTICUT PATH
Westborough, MA 01581

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $1.69MM
First Award Date 08/25/00
Most Recent Award Date 08/01/04

Key Personnel

Last Name Name Awards Contact
Yalpani Manssur Yalpani 7 Message

7 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/04 - 07/31/08

DESCRIPTION (provided by applicant): Diabetes affects some 20 million people in the U.S. The World Health Organization expects the global diabetics population to rise from 130 million to 350 million by 2025. Diabetes therapy based on transplanted islets or insulin-secreting Beta cells offers substantial advantages over conventional treatments....

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/10/03 - 07/31/04

DESCRIPTION (provided by applicant): Diabetes affects some 20 million people in the U.S. The World Health Organization expects the global diabetics population to rise from 130 million to 350 million by 2025. Diabetes therapy based on transplanted islets or insulin-secreting Beta cells offers substantial advantages over conventional treatments....

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/02 - 08/31/03

DESCRIPTION (provided by applicant):New bio compatible probes are proposed for magnetic resonance imaging (MRI). 19F based probes will be prepared that are more suitable than existing products for rapid and sensitive oxygen mapping using 19F MRI. These probes will be employed to assess in a model system the viability, metabolic rate and oxygen c...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/02 - 07/31/03

DESCRIPTION (provided by applicant): The incidence of diabetes mellitus in adults is on the rise globally and constitutes a major health problem. We are proposing the development of a new encapsulated glucose-responsive insulin secreting cell implants for the treatment of type I diabetes, using poly(gamma-glutamic acid) (gamma-PGA). Previously ...

Phase 1 SBIR

Agency: National Science Foundation
Topic: 2002
Budget: 01/01/02 - 12/31/02

This Small Business Innovation Research (SBIR) Phase I project proposes to develop a new biopolymer for primary metal removal and a poly-g-glutamic acid (g-PGA)diafiltration system for recovery of metals from dilute solutions. Preliminary results obtained to date indicate that this process holds considerable promise in effectively removing meta...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/00 - 08/31/01

We are proposing the development of new biocompatible biomaterials for biomedical uses and specifically for the preparation of separation devices. The new biomaterials can be readily derived with a high yielding, cost-effective proprietary process that also permits the preparation of a range of different compositions. Preliminary data from pilot...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/25/00 - 07/31/01

Current therapeutics for Alzheimer's disease (AD), the most prevalent cause of dementia, offer only modest curtailments in the progression of cognitive impairment. We propose to identify compounds that could serve as effective prophylactics or therapeutics for neurodegeneration. Aberrant expression of the nitric oxide synthase III (NOS III) gene...